ASGN INC (ASGN) Fundamental Analysis & Valuation

NYSE:ASGN • US00191U1025

Current stock price

37.56 USD
-2.34 (-5.86%)
At close:
37.56 USD
0 (0%)
After Hours:

This ASGN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ASGN Profitability Analysis

1.1 Basic Checks

  • ASGN had positive earnings in the past year.
  • In the past year ASGN had a positive cash flow from operations.
  • ASGN had positive earnings in each of the past 5 years.
  • In the past 5 years ASGN always reported a positive cash flow from operatings.
ASGN Yearly Net Income VS EBIT VS OCF VS FCFASGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • ASGN has a better Return On Assets (3.09%) than 61.36% of its industry peers.
  • Looking at the Return On Equity, with a value of 6.29%, ASGN is in the better half of the industry, outperforming 61.36% of the companies in the same industry.
  • The Return On Invested Capital of ASGN (5.50%) is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for ASGN is below the industry average of 11.08%.
Industry RankSector Rank
ROA 3.09%
ROE 6.29%
ROIC 5.5%
ROA(3y)4.79%
ROA(5y)6.71%
ROE(3y)9.25%
ROE(5y)12.76%
ROIC(3y)6.8%
ROIC(5y)7.58%
ASGN Yearly ROA, ROE, ROICASGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • The Profit Margin of ASGN (2.85%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of ASGN has declined.
  • Looking at the Operating Margin, with a value of 6.29%, ASGN is in line with its industry, outperforming 57.95% of the companies in the same industry.
  • ASGN's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 28.87%, ASGN is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
  • ASGN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.29%
PM (TTM) 2.85%
GM 28.87%
OM growth 3Y-13.5%
OM growth 5Y-6.34%
PM growth 3Y-21.31%
PM growth 5Y-13%
GM growth 3Y-1.16%
GM growth 5Y1.31%
ASGN Yearly Profit, Operating, Gross MarginsASGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ASGN Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ASGN is destroying value.
  • The number of shares outstanding for ASGN has been reduced compared to 1 year ago.
  • The number of shares outstanding for ASGN has been reduced compared to 5 years ago.
  • The debt/assets ratio for ASGN is higher compared to a year ago.
ASGN Yearly Shares OutstandingASGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ASGN Yearly Total Debt VS Total AssetsASGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.41 indicates that ASGN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ASGN has a Altman-Z score of 2.41. This is comparable to the rest of the industry: ASGN outperforms 51.14% of its industry peers.
  • The Debt to FCF ratio of ASGN is 4.06, which is a neutral value as it means it would take ASGN, 4.06 years of fcf income to pay off all of its debts.
  • ASGN has a Debt to FCF ratio (4.06) which is in line with its industry peers.
  • ASGN has a Debt/Equity ratio of 0.65. This is a neutral value indicating ASGN is somewhat dependend on debt financing.
  • ASGN has a Debt to Equity ratio of 0.65. This is comparable to the rest of the industry: ASGN outperforms 43.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.06
Altman-Z 2.41
ROIC/WACC0.62
WACC8.92%
ASGN Yearly LT Debt VS Equity VS FCFASGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • ASGN has a Current Ratio of 2.16. This indicates that ASGN is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.16, ASGN is doing good in the industry, outperforming 62.50% of the companies in the same industry.
  • ASGN has a Quick Ratio of 2.16. This indicates that ASGN is financially healthy and has no problem in meeting its short term obligations.
  • ASGN's Quick ratio of 2.16 is fine compared to the rest of the industry. ASGN outperforms 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 2.16
ASGN Yearly Current Assets VS Current LiabilitesASGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ASGN Growth Analysis

3.1 Past

  • The earnings per share for ASGN have decreased strongly by -13.00% in the last year.
  • The Earnings Per Share has been decreasing by -1.19% on average over the past years.
  • The Revenue has decreased by -2.91% in the past year.
  • ASGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.59% yearly.
EPS 1Y (TTM)-13%
EPS 3Y-11.57%
EPS 5Y-1.19%
EPS Q2Q%-10.16%
Revenue 1Y (TTM)-2.91%
Revenue growth 3Y-4.58%
Revenue growth 5Y2.59%
Sales Q2Q%-0.5%

3.2 Future

  • ASGN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.35% yearly.
  • ASGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.63% yearly.
EPS Next Y12.79%
EPS Next 2Y14.45%
EPS Next 3Y16.35%
EPS Next 5YN/A
Revenue Next Year1.41%
Revenue Next 2Y3.16%
Revenue Next 3Y3.63%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ASGN Yearly Revenue VS EstimatesASGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
ASGN Yearly EPS VS EstimatesASGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. ASGN Valuation Analysis

4.1 Price/Earnings Ratio

  • ASGN is valuated reasonably with a Price/Earnings ratio of 8.25.
  • ASGN's Price/Earnings ratio is rather cheap when compared to the industry. ASGN is cheaper than 86.36% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 24.88. ASGN is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 7.32 indicates a rather cheap valuation of ASGN.
  • Based on the Price/Forward Earnings ratio, ASGN is valued cheaply inside the industry as 85.23% of the companies are valued more expensively.
  • ASGN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.25
Fwd PE 7.32
ASGN Price Earnings VS Forward Price EarningsASGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 81.82% of the companies in the same industry are more expensive than ASGN, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ASGN is valued cheaper than 93.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.38
EV/EBITDA 7.3
ASGN Per share dataASGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • ASGN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ASGN's earnings are expected to grow with 16.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.65
PEG (5Y)N/A
EPS Next 2Y14.45%
EPS Next 3Y16.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ASGN Dividend Analysis

5.1 Amount

  • ASGN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ASGN Fundamentals: All Metrics, Ratios and Statistics

ASGN INC

NYSE:ASGN (3/27/2026, 8:04:00 PM)

After market: 37.56 0 (0%)

37.56

-2.34 (-5.86%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-04
Earnings (Next)04-21
Inst Owners99.83%
Inst Owner Change-4.13%
Ins Owners4.16%
Ins Owner Change10.35%
Market Cap1.55B
Revenue(TTM)3.98B
Net Income(TTM)113.50M
Analysts72.31
Price Target55.59 (48%)
Short Float %6.28%
Short Ratio3.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.4%
Min EPS beat(2)-4.1%
Max EPS beat(2)4.9%
EPS beat(4)2
Avg EPS beat(4)0.38%
Min EPS beat(4)-5.06%
Max EPS beat(4)5.79%
EPS beat(8)6
Avg EPS beat(8)1.41%
EPS beat(12)9
Avg EPS beat(12)1.69%
EPS beat(16)11
Avg EPS beat(16)2.03%
Revenue beat(2)0
Avg Revenue beat(2)-1.3%
Min Revenue beat(2)-1.33%
Max Revenue beat(2)-1.27%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)0.55%
Revenue beat(8)1
Avg Revenue beat(8)-1.7%
Revenue beat(12)1
Avg Revenue beat(12)-1.78%
Revenue beat(16)2
Avg Revenue beat(16)-1.43%
PT rev (1m)3.15%
PT rev (3m)11.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.15%
EPS NY rev (1m)1.18%
EPS NY rev (3m)2.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.81%
Revenue NY rev (1m)0.83%
Revenue NY rev (3m)0.91%
Valuation
Industry RankSector Rank
PE 8.25
Fwd PE 7.32
P/S 0.39
P/FCF 5.38
P/OCF 4.73
P/B 0.86
P/tB N/A
EV/EBITDA 7.3
EPS(TTM)4.55
EY12.11%
EPS(NY)5.13
Fwd EY13.66%
FCF(TTM)6.98
FCFY18.57%
OCF(TTM)7.94
OCFY21.14%
SpS96.38
BVpS43.68
TBVpS-19.2
PEG (NY)0.65
PEG (5Y)N/A
Graham Number66.87
Profitability
Industry RankSector Rank
ROA 3.09%
ROE 6.29%
ROCE 7.7%
ROIC 5.5%
ROICexc 5.78%
ROICexgc 36.14%
OM 6.29%
PM (TTM) 2.85%
GM 28.87%
FCFM 7.24%
ROA(3y)4.79%
ROA(5y)6.71%
ROE(3y)9.25%
ROE(5y)12.76%
ROIC(3y)6.8%
ROIC(5y)7.58%
ROICexc(3y)7.22%
ROICexc(5y)8.22%
ROICexgc(3y)39.78%
ROICexgc(5y)44.2%
ROCE(3y)9.53%
ROCE(5y)10.62%
ROICexgc growth 3Y-11.4%
ROICexgc growth 5Y-4.45%
ROICexc growth 3Y-17.62%
ROICexc growth 5Y-7.28%
OM growth 3Y-13.5%
OM growth 5Y-6.34%
PM growth 3Y-21.31%
PM growth 5Y-13%
GM growth 3Y-1.16%
GM growth 5Y1.31%
F-Score4
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 4.06
Debt/EBITDA 3.21
Cap/Depr 35.07%
Cap/Sales 1%
Interest Coverage 3.74
Cash Conversion 90.08%
Profit Quality 253.83%
Current Ratio 2.16
Quick Ratio 2.16
Altman-Z 2.41
F-Score4
WACC8.92%
ROIC/WACC0.62
Cap/Depr(3y)37.17%
Cap/Depr(5y)38.25%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.89%
Profit Quality(3y)217.38%
Profit Quality(5y)158.35%
High Growth Momentum
Growth
EPS 1Y (TTM)-13%
EPS 3Y-11.57%
EPS 5Y-1.19%
EPS Q2Q%-10.16%
EPS Next Y12.79%
EPS Next 2Y14.45%
EPS Next 3Y16.35%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.91%
Revenue growth 3Y-4.58%
Revenue growth 5Y2.59%
Sales Q2Q%-0.5%
Revenue Next Year1.41%
Revenue Next 2Y3.16%
Revenue Next 3Y3.63%
Revenue Next 5YN/A
EBIT growth 1Y-17.71%
EBIT growth 3Y-17.46%
EBIT growth 5Y-3.91%
EBIT Next Year71.07%
EBIT Next 3Y26.6%
EBIT Next 5YN/A
FCF growth 1Y-21%
FCF growth 3Y2.15%
FCF growth 5Y-5.98%
OCF growth 1Y-18.02%
OCF growth 3Y2.13%
OCF growth 5Y-5.05%

ASGN INC / ASGN Fundamental Analysis FAQ

What is the fundamental rating for ASGN stock?

ChartMill assigns a fundamental rating of 5 / 10 to ASGN.


What is the valuation status of ASGN INC (ASGN) stock?

ChartMill assigns a valuation rating of 8 / 10 to ASGN INC (ASGN). This can be considered as Undervalued.


How profitable is ASGN INC (ASGN) stock?

ASGN INC (ASGN) has a profitability rating of 4 / 10.


How financially healthy is ASGN INC?

The financial health rating of ASGN INC (ASGN) is 5 / 10.


What is the expected EPS growth for ASGN INC (ASGN) stock?

The Earnings per Share (EPS) of ASGN INC (ASGN) is expected to grow by 12.79% in the next year.